These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

501 related items for PubMed ID: 28743511

  • 1. Raf-1/CK2 and RhoA/ROCK signaling promote TNF-α-mediated endothelial apoptosis via regulating vimentin cytoskeleton.
    Yang L, Tang L, Dai F, Meng G, Yin R, Xu X, Yao W.
    Toxicology; 2017 Aug 15; 389():74-84. PubMed ID: 28743511
    [Abstract] [Full Text] [Related]

  • 2. RhoA/ROCK signaling regulates smooth muscle phenotypic modulation and vascular remodeling via the JNK pathway and vimentin cytoskeleton.
    Tang L, Dai F, Liu Y, Yu X, Huang C, Wang Y, Yao W.
    Pharmacol Res; 2018 Jul 15; 133():201-212. PubMed ID: 29791873
    [Abstract] [Full Text] [Related]

  • 3. Distinct Roles For ROCK1 and ROCK2 in the Regulation of Oxldl-Mediated Endothelial Dysfunction.
    Huang L, Dai F, Tang L, Bao X, Liu Z, Huang C, Zhang T, Yao W.
    Cell Physiol Biochem; 2018 Jul 15; 49(2):565-577. PubMed ID: 30165352
    [Abstract] [Full Text] [Related]

  • 4. [TNF-α activates RhoA/ROCK signaling pathway and increases permeability of endothelial cells infected with Listeria monocytogenes].
    Lu Y, Lian Z, Yang H, Jiang Q, Zou Y, Zhu Y, Ling W, Yuan L, Jiang X, Chen S.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2020 Mar 15; 36(3):193-197. PubMed ID: 32389165
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of RhoA/ROCK signaling pathway promotes the apoptosis of gastric cancer cells.
    Xu XT, Song QB, Yao Y, Ruan P, Tao ZZ.
    Hepatogastroenterology; 2012 Mar 15; 59(120):2523-6. PubMed ID: 22584506
    [Abstract] [Full Text] [Related]

  • 6. Deoxypodophyllotoxin suppresses tumor vasculature in HUVECs by promoting cytoskeleton remodeling through LKB1-AMPK dependent Rho A activatio.
    Wang Y, Wang B, Guerram M, Sun L, Shi W, Tian C, Zhu X, Jiang Z, Zhang L.
    Oncotarget; 2015 Oct 06; 6(30):29497-512. PubMed ID: 26470595
    [Abstract] [Full Text] [Related]

  • 7. Tetrahydroxystilbene glucoside protects against LPS-induced endothelial dysfunction via inhibiting RhoA/ROCK signaling and F-actin remodeling.
    Qi Y, Liang X, Hu X, He H, Tang L, Yao W.
    Gen Physiol Biophys; 2020 Sep 06; 39(5):407-417. PubMed ID: 33084595
    [Abstract] [Full Text] [Related]

  • 8. RhoA/ROCK-dependent moesin phosphorylation regulates AGE-induced endothelial cellular response.
    Wang J, Liu H, Chen B, Li Q, Huang X, Wang L, Guo X, Huang Q.
    Cardiovasc Diabetol; 2012 Jan 17; 11():7. PubMed ID: 22251897
    [Abstract] [Full Text] [Related]

  • 9. GEF-H1/RhoA signalling pathway mediates lipopolysaccharide-induced intercellular adhesion molecular-1 expression in endothelial cells via activation of p38 and NF-κB.
    Guo F, Zhou Z, Dou Y, Tang J, Gao C, Huan J.
    Cytokine; 2012 Mar 17; 57(3):417-28. PubMed ID: 22226621
    [Abstract] [Full Text] [Related]

  • 10. High glucose activates Raw264.7 macrophages through RhoA kinase-mediated signaling pathway.
    Cheng CI, Chen PH, Lin YC, Kao YH.
    Cell Signal; 2015 Feb 17; 27(2):283-92. PubMed ID: 25446262
    [Abstract] [Full Text] [Related]

  • 11. [Tumor necrosis factor-α promote permeability of human umbilical vein endothelial cells via activating RhoA-ERK1/2 pathway].
    Yan CH, Yu HB, Huang MF, Li J, Zhang XL, Han YL.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Jun 17; 39(6):531-7. PubMed ID: 21924080
    [Abstract] [Full Text] [Related]

  • 12. Anti-inflammatory mechanism of ulinastatin: Inhibiting the hyperpermeability of vascular endothelial cells induced by TNF-α via the RhoA/ROCK signal pathway.
    Wei F, Liu S, Luo L, Gu N, Zeng Y, Chen X, Xu S, Zhang D.
    Int Immunopharmacol; 2017 May 17; 46():220-227. PubMed ID: 28329735
    [Abstract] [Full Text] [Related]

  • 13. Vascular endothelial growth factor C promotes cervical cancer metastasis via up-regulation and activation of RhoA/ROCK-2/moesin cascade.
    He M, Cheng Y, Li W, Liu Q, Liu J, Huang J, Fu X.
    BMC Cancer; 2010 Apr 29; 10():170. PubMed ID: 20429915
    [Abstract] [Full Text] [Related]

  • 14. Low-Dose Endothelial Monocyte-Activating Polypeptide-II Increases Blood-Tumor Barrier Permeability by Activating the RhoA/ROCK/PI3K Signaling Pathway.
    Li Z, Liu XB, Liu YH, Xue YX, Liu J, Teng H, Xi Z, Yao YL.
    J Mol Neurosci; 2016 Jun 29; 59(2):193-202. PubMed ID: 26521255
    [Abstract] [Full Text] [Related]

  • 15. Involvement of RhoA/ROCK1 signaling pathway in hyperglycemia-induced microvascular endothelial dysfunction in diabetic retinopathy.
    Lu QY, Chen W, Lu L, Zheng Z, Xu X.
    Int J Clin Exp Pathol; 2014 Jun 29; 7(10):7268-77. PubMed ID: 25400825
    [Abstract] [Full Text] [Related]

  • 16. cGMP signaling inhibits platelet shape change through regulation of the RhoA-Rho Kinase-MLC phosphatase signaling pathway.
    Aburima A, Walladbegi K, Wake JD, Naseem KM.
    J Thromb Haemost; 2017 Aug 29; 15(8):1668-1678. PubMed ID: 28509344
    [Abstract] [Full Text] [Related]

  • 17. Progesterone Inhibits Endothelial Cell Migration Through Suppression of the Rho Activity Mediated by cSrc Activation.
    Lee TS, Lin JJ, Huo YN, Lee WS.
    J Cell Biochem; 2015 Jul 29; 116(7):1411-8. PubMed ID: 25754581
    [Abstract] [Full Text] [Related]

  • 18. TGR5 receptor activation attenuates diabetic retinopathy through suppression of RhoA/ROCK signaling.
    Zhu L, Wang W, Xie TH, Zou J, Nie X, Wang X, Zhang MY, Wang ZY, Gu S, Zhuang M, Tan J, Shen C, Dai Y, Yang X, Yao Y, Wei TT.
    FASEB J; 2020 Mar 29; 34(3):4189-4203. PubMed ID: 31957105
    [Abstract] [Full Text] [Related]

  • 19. Zoledronate inhibits endothelial cell adhesion, migration and survival through the suppression of multiple, prenylation-dependent signaling pathways.
    Hasmim M, Bieler G, Rüegg C.
    J Thromb Haemost; 2007 Jan 29; 5(1):166-73. PubMed ID: 17059425
    [Abstract] [Full Text] [Related]

  • 20. α-TEA inhibits the growth and motility of human colon cancer cells via targeting RhoA/ROCK signaling.
    Yao J, Gao P, Xu Y, Li Z.
    Mol Med Rep; 2016 Sep 29; 14(3):2534-40. PubMed ID: 27432222
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.